- Home
- ORGO vs ASGI Comparison
ORGO vs ASGI Comparison
Compare ORGO & ASGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORGO
- ASGI
- Stock Information
- Founded
- ORGO 1985
- ASGI 2019
- Country
- ORGO United States
- ASGI United States
- Employees
- ORGO N/A
- ASGI N/A
- Industry
- ORGO Biotechnology: Pharmaceutical Preparations
- ASGI Investment Managers
- Sector
- ORGO Health Care
- ASGI Finance
- Exchange
- ORGO Nasdaq
- ASGI Nasdaq
- Market Cap
- ORGO 465.6M
- ASGI 554.6M
- IPO Year
- ORGO N/A
- ASGI N/A
- Fundamental
- Price
- ORGO $4.32
- ASGI $20.71
- Analyst Decision
- ORGO Hold
- ASGI
- Analyst Count
- ORGO 1
- ASGI 0
- Target Price
- ORGO $6.00
- ASGI N/A
- AVG Volume (30 Days)
- ORGO 918.2K
- ASGI 83.3K
- Earning Date
- ORGO 08-07-2025
- ASGI 01-01-0001
- Dividend Yield
- ORGO N/A
- ASGI 8.76%
- EPS Growth
- ORGO N/A
- ASGI N/A
- EPS
- ORGO N/A
- ASGI N/A
- Revenue
- ORGO $458,760,000.00
- ASGI N/A
- Revenue This Year
- ORGO $1.10
- ASGI N/A
- Revenue Next Year
- ORGO $9.93
- ASGI N/A
- P/E Ratio
- ORGO N/A
- ASGI N/A
- Revenue Growth
- ORGO 5.35
- ASGI N/A
- 52 Week Low
- ORGO $2.28
- ASGI $14.96
- 52 Week High
- ORGO $6.71
- ASGI $18.55
- Technical
- Relative Strength Index (RSI)
- ORGO 68.34
- ASGI 70.61
- Support Level
- ORGO $3.59
- ASGI $20.45
- Resistance Level
- ORGO $4.70
- ASGI $20.72
- Average True Range (ATR)
- ORGO 0.23
- ASGI 0.20
- MACD
- ORGO 0.12
- ASGI 0.02
- Stochastic Oscillator
- ORGO 81.15
- ASGI 89.09
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
About ASGI abrdn Global Infrastructure Income Fund of Beneficial Interest
abrdn Global Infrastructure Income Fund is a non-diversified, closed-end management investment company. Its objective is to seek to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society.